SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-16-003062
Filing Date
2016-10-25
Accepted
2016-10-25 13:35:45
Documents
6
Period of Report
2016-11-16
Effectiveness Date
2016-10-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE SCHEDULE 14A innvdef14a.htm DEF 14A 780222
2 IMAGE fax.jpg GRAPHIC 1209
3 IMAGE internet.jpg GRAPHIC 999
4 IMAGE mail.jpg GRAPHIC 997
5 IMAGE phone.jpg GRAPHIC 1142
6 IMAGE please.jpg GRAPHIC 5135
  Complete submission text file 0001654954-16-003062.txt   795073
Mailing Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122
Business Address 9171 TOWNE CENTRE DRIVE, SUITE 440 SAN DIEGO CA 92122 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

IRS No.: 900814124 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-52991 | Film No.: 161950009
SIC: 2834 Pharmaceutical Preparations